Neurocrine Biosciences
NBIX | NASDAQ
$165.42
-$1.98 (-1.18%)
At close: Nov 16, 2026, 4:00 PM ET
$157.34
-$8.08 (-4.88%)
Pre-market:
Nov 17, 2026, 4:00 AM ET
Neurocrine Biosciences Employees
Company profile explainedEmployees
2,000
Change (1Y)
200
Growth (1Y)
+11.11%
Revenue / Employee
$1,480,680
Profits / Employee
$281,000
Market Cap
$16.74B
Employees History
| Date | Employees | Change | % Change |
|---|---|---|---|
| Dec 31, 2025 | 2,000 | 200 | +11.11% |
| Dec 31, 2024 | 1,800 | 400 | +28.57% |
| Dec 31, 2023 | 1,400 | 200 | +16.67% |
| Dec 31, 2022 | 1,200 | 300 | +33.33% |
| Dec 31, 2021 | 900 | 55 | +6.51% |
| Dec 31, 2020 | 845 | 145 | +20.71% |
| Dec 31, 2019 | 700 | 115 | +19.66% |
| Dec 31, 2018 | 585 | 185 | +46.25% |
| Dec 31, 2017 | 400 | 204 | +104.08% |
| Dec 31, 2016 | 196 | 76 | +63.33% |
| Dec 31, 2015 | 120 | 26 | +27.66% |
| Dec 31, 2014 | 94 | 13 | +16.05% |
| Dec 31, 2013 | 81 | 3 | +3.85% |
| Dec 31, 2012 | 78 | 7 | +9.86% |
| Dec 31, 2011 | 71 | 5 | +7.58% |
| Dec 31, 2010 | 66 | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NBIX